RSS Feed

EIC Accelerator pilot in numbers - EASME report available

EASME, the European Commisssion's Executive Agency for SMEs, has just published their 2014-2018 report on the EIC Accelerator pilot.

The EIC Accelerator pilot – previously known as the SME Instrument – carefully selects the best innovators in Europe and aims to bridge the critical investment gap in early-stage innovation, making the companies an ideal investment opportunity for follow-up investment from private entities. The 2019 edition of the Innovation Kitchen report presents the portfolio of successful companies emerging from Europe’s most wanted innovation funding programme for small businesses.

Since the start of the programme in 2014 the EIC Accelerator pilot (SME Instrument) has helped over 4400 companies get a head start in the race to the market. The programme offers up to € 2.5 million in funding, innovation coaching and business acceleration services.

More than two-thirds of the companies have placed their product on the market, since they received support from the EIC pilot. 17 companies float on the stock exchange market, 33 have been acquired and a total of € 3 billion of extra private follow-up investment has been leveraged.

Over 75% of the companies funded have increased their operating revenues. Companies have also grown in size as around 67% of them have increased their headcount since the grant.

Source: EASME

Post-Brexit scenarios

Regarding the participation of British researchers in Horizon 2020 projects, UK Research and Innovation’s (UKRI) Brussels-based UK Research Office (UKRO) is maintaining and regularly updating a factsheet providing the latest information on the current situation.

If the Withdrawal Agreement is ratified before Brexit, UK participation in Horizon 2020 will be ensured until the end of the programme and for the lifetime of projects. 

In the event of a no-deal scenario, different rules will apply depending on whether UK bids to EU calls have been submitted before 31 October 2019 or after. 

If UK bids to EU calls have been submitted before 31 October 2019, in case of a no-deal brexit the UK government has committed to guarantee competitive UK bids to EU funding submitted before exit, even if they are notified of their success after exit, for the lifetime of the projects.

If UK bids to EU calls have been submitted after 31 October 2019, the funding for successful UK bids will be guaranteed not by the EU but by UKRI itself, which has been appointed to administer the UK’s guarantee and post-EU exit extension. The funding then will be ensured for the lifetime of such projects, even if they last beyond 2020. The UK government is seeking discussions with the European Commission to agree the details of the UK’s continued participation as a third country.

Sources Swisscore, UKRI

IMI patient expert pool

IMI is creating a pool of patient experts to strengthen the role and voice of patients in IMI activities. Patients, their families and care givers were invited to join and IMI is now about to start building this pool based on a first round of expressions of interest received.

Whenever a task comes up at IMI that would benefit from patient/carer input, IMI will select patients from this pool to get involved.

How to implement Horizon Europe? Share your views with the EC!

The European Commission has launched a survey on how best to implement the new EU funded reasearch and innovation programme "Horizon Europe".

How should the rules, processes, systems, documents and guidance look like to ensure that the policy objectives are reached, the programme is attractive for all its users and the European citizens can benefit most of it?

Express yourself! This survey is open to all and you can acceed it here.

NEURONET Coordination and Support Action on neurodegeneration research.

We are pleased to announce the NEURONET Coordination and Support Action on neurodegeneration research.

NEURONET is a three-year coordination and support action that kicked off in March 2019. The aim of NEURONET is to set up an efficient platform to boost collaboration across research projects focusing on neurodegenerative diseases, including but not limited to Alzheimer’s disease.

Enjoy browsing their website which also links to a network of existing IMI projects in the field, amongst which our project IMPRiND is proud to be.

Guidelines for SSH Integration in mission-oriented research programmes

A new guideline gives practical advice on how to design and implement mission-oriented research programmes by integrating SSH from the start.

In November 2018, the Austrian Presidency organised a conference in Vienna discussing the impact of Social Sciences and Humanities (SSH) for a European research agenda. As a main result, the organisers of the conference under the lead of Thomas König, researcher at the Insitut für Höhere Studien in Vienna, have now published the document ‘Social Sciences and Humanities Research Matters. Guidelines on how to successfully design, and implement, mission-oriented research programmes’.

The document is aimed at all stakeholders dealing with research funding programmes and includes practical advice for the full exploitation of interdisciplinary cooperation to tackle societal challenges. Such societal challenges are often addressed in ‘mission-oriented’ research programmes setting out a specific goal. The guidelines urge stakeholders to move from an integration of SSH to full cooperation right from the design of a research funding programme all the way through to implementation. The authors give examples of actions that programme officers, reviewers and panellists or independent evaluators can use to take SSH research into account. The recommendations given in the guideline may apply to the design of new instruments within Horizon Europe, such as the missions.

For more information kindly refer to the European Commission's portal for Social sciences and humanities. 

Source: Swisscore

IMI2: New Call for proposals to be launched on 22 January! Sign up for webinars!

The Innovative Medicines Initiative (IMI2) will launch their next call for proposals, Call 17 on 22 Jan 2019. 

The following topics are under consideration for inclusion in this next IMI Call for proposals.

Optimising future obesity treatment
Open access chemogenomics library and chemical probes for the druggable genome
Intelligent prediction and identification of environmental risks posed by human medicinal products 

These topics are now at an advanced stage of development and these drafts shall allow potential applicants to start working actively on proposals and forming consortia. Nevertheless, these topics must still be approved by the IMI Governing Board. The final topic text may differ from the draft versions published, and applicants should always base their proposals on the final, approved topic texts which will be published when the Call is officially launched.

In preparation of this call, IMI-JU organises webinars from 23 to 31 January 2019.

All webinars on the Call topics will feature a presentation by the EFPIA topic coordinator and time for questions and answers. The webinars represent an excellent opportunity to learn more about the Call topics, interact directly with the topic coordinators, and get in touch with potential project partners.

The webinar on IMI’s rules and procedures will include presentations of IMI's intellectual property policy and tips on the preparation of proposal submissions. IMI will also hold a dedicated webinar for small and medium-sized enterprises (SMEs). This will cover elements of the different Call topics that may be of particular relevance for SMEs, as well as a presentation of IMI’s rules and procedures with a focus on aspects that are most important for SMEs.

Source: IMI-JU

Health EU CSA proposal successfully submitted!

We have successfully submitted the Health EU CSA proposal! 
  • With the ambitious unifying goal of empowering every citizen with a Human Avatar enabling access to comprehensive personalized healthcare, healthy lifestyle and disease prevention.
  • With a Consortium of 110 partners from 27 European countries, Canada and New Zealand, more than 75 stakeholders and hundreds of enthusiastic supporters across Europe.
  • With an International Advisory Board including 2 Nobel Laureates, several ex-Ministers of Health of EU countries and many international leaders and experts in Europe, USA, and Canada.
Many thanks to all the Consortium contributors, to the Strategic Board members and to Workpackage and Task Leaders, for their hard work and the outstanding product!
We are proud to be part of this endeavour!
For more information about this FET flagship proposal please refer to the Health EU website

Towards full open access: cOALition S

On 4 September 2018, a group of national research funding organisations, with the support of the European Commission and the European Research Council (ERC), announced the launch of cOAlition S, an initiative to make full and immediate Open Access to research publications a reality. It is built around Plan S, which consists of one target and 10 principles.
cOAlition S signals the commitment to implement, by 1 January 2020, the necessary measures to fulfil its main principle: By 2020 scientific publications that result from research funded by public grants provided by participating national and European research councils and funding bodies, must be published in compliant Open Access Journals or on compliant Open Access Platforms.”
Currently 12 national research funding organisations form cOAlition S and they have agreed to implement the 10 principles of Plan S in a coordinated way, together with the European Commission and the ERC. Other research funders from across the world, both public and private, are invited to join cOAlition S.
The initiative was born from the cooperation between the Heads of the participating Research Funding Organisations, Marc Schiltz the President of Science Europe, and Robert-Jan Smits the Open Access Envoy of the European Commission. It also drew on significant input from the Scientific Council of the ERC.
The research funders involved in cOAlition S will now collaborate with other stakeholders and work towards swift and practical implementation of these principles.
For more information about cOALition S and the "10 Principles of Plan S" please refer to the initiative's website
Source: Swisscore, Science Europe

Database on Funding Activities for Personalised Medicine (PM) Research Has Been Launched

The International Consortium for Personalised Medicine (ICPerMed) database, launched on 5 July 2018, gives an overview on the actions in the field of personalised medicine performed in the ICPerMed member states and may assist interested users in finding suitable funding opportunities and information about potential funders in their respective country and/or region.
The access to the data requires simple registration here.
The first ICPerMed Conference ‘Personalised Medicine in Action’ will take place on 20-21 November 2018 in Berlin, Germany. Registration is now open.
Sources: ICPerMed, Euresearch

See Older Posts...